|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 33 of 108 found articles
| Title: |
75P Efficacy and updated safety results from pivotal phase II trial 201 of naxitamab (Hu3F8): A humanized GD2-targeted immunotherapy for the treatment of refractory/relapsed (R/R) high-risk (HR) neuroblastoma (NB) |
| Author: |
Mora, J. Chan, G.C. Morgenstern, D.A. Nysom, K. Bear, M. Dalby, L. Worsaae Lisby, S. Kushner, B.H. |
| Appeared in: |
Annals of oncology |
| Paging: | Volume 31 () nr. S7 pages S1448 |
| Year: |
2020 |
| Contents: | |
| Publisher: |
European Society for Medical Oncology |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 33 of 108 found articles
| << previous | next >> |